Annexonbio.com receives about 409 visitors in one month. That could possibly earn $2.05 each month or $0.07 each day. Server of the website is located in the United States. Annexonbio.com main page was reached and loaded in 0.96 seconds. This is a good result. Try the services listed at the bottom of the page to search for available improvements.
Is annexonbio.com legit? | |
Website Value | $37 |
Alexa Rank | 8825197 |
Monthly Visits | 409 |
Daily Visits | 14 |
Monthly Earnings | $2.05 |
Daily Earnings | $0.07 |
Country: United States
Metropolitan Area: Not defined
Postal Reference Code: Not defined
Latitude: 37.751
Longitude: -97.822
HTML Tag | Content | Informative? |
---|---|---|
Title: | Neurodegenerative Disorders | Alzheimer | Huntington’s disease | Annexon | ![]() |
Description: | Annexon Biosciences is leading the development of therapeutic products that halt the progression of complement-mediated neurodegeneration | ![]() |
H2: | Science | Is it informative enough? |
Results will appear here |
|
Pingdom - Web transfer-speed test from Pingdom
Run diagnostic transfer-rate tests on each page or individual page components (JS, .img, and HTML code) with Pingdom for annexonbio.com
Google’s Web Analytics Google provides many analytical tools for the web that will help you find out the number of visitors, their locations and activities when logging onto annexonbio.com
Alexa - annexonbio.com on Alexa Traffic Rank Data
Alexa provides a charting service that shows global position by audience, engagement, and time spent on annexonbio.com
Majestic Backlinks - Lookup other webpages that have hyperlinks leading to annexonbio.com.
Google Index - Which of the pages is Google.com indexing?
Find out which pages from annexonbio.com have made it into Google.com’s listings. You can find out with the "site:" query.
Website on this IP by Bing - All sites on the same 69.63.141.106 IP
View a list of websites with an IP matching that of annexonbio.com from Bing.com
/science/: | |
---|---|
Title |
Neurodegenerative Disorders | The cl ical compliment pathway | Annexon Biosciences [censored]
|
Description |
Annexon Biosciences is leading the development of the utic products that halt the progression of complement-mediated neurodegeneration (CMND). [censored]
|
H1 |
Our Science |
H2 |
Autoimmune diseases |
/team/leadership/: | |
---|---|
Title |
Leadership | Alzheimer | Huntington’s disease | Annexon Biosciences |
Description |
Annexon’s leadership has an extensive and successful track-record of discovering, developing and commercializing breakthrough therapies for debilitating disease. |
H1 |
Leadership |
H2 |
Douglas Love, Esq |
/news/121918/: | |
---|---|
Title |
December 19, 2018 Press Release | Annexon Biosciences |
Description |
Not defined |
H1 |
Annexon Biosciences Closes $75 Million Financing |
H2 |
Proceeds support the clinical development of multiple product candidates inhibiting the cl ical complement pathway in autoimmune, ophthalmic and neurodegenerative disorders [censored]
|
H3 |
About Annexon Biosciences |
/news/: | |
---|---|
Title |
News: Neurodegenerative Disorders | Alzheimer | Huntington’s disease | Annexon Biosciences |
Description |
The latest news from Annexon. Annexon Biosciences is leading the development of the utic products that halt the progression of complement-mediated neurodegeneration (CMND). [censored]
|
H2 |
In The News |
/team/board/: | |
---|---|
Title |
Board of Directors | Neurodegenerative Disorders | Annexon Biosciences |
Description |
Annexon’s Board of Directors is comprised of accomplished, global biotechnology and pharmaceutical leaders. Annexon Biosciences is leading the development of the utic products that halt the progression of complement-mediated neurodegeneration (CMND). [censored]
|
H2 |
William (Bill) Young, Board Chair |
Similar domain names
annexonchicago.comannexonegame.comannexonline.organnexofsb.comannexofannarbor.infoannexoap.com
You took 89.95 and 84.95 at the same time from my back account that i didnt authorize and was apparently hacked. I...